SOURCE: Zenect Wealth

Zenect Wealth

August 18, 2011 06:00 ET

New Report on Winner Medical (WWIN), China Shen Zhou (SHZ), and Tianyin Pharmaceutical (TPI) Issued by

PHOENIX, AZ--(Marketwire - Aug 18, 2011) - is a financial newsletter publisher offering investment reports on penny stocks and small cap companies in China. They recently completed analytical research on three China based companies, Winner Medical (WWIN), China Shen Zhou (SHZ), and Tianyin Pharmaceutical (TPI).

All three reports are available for free at Winner Medical (WWIN) is a worldwide designer, manufacturer and exporter of primarily cotton based medical supplies.

Tianyin Pharmaceutical (TPI) provides medications in China. Their products include patented medicines, generics, and modernized traditional Chinese medicinal treatments.

China Shen Zhou (SHZ) is a mining company operating in northern China. Their primary sources of revenue are Flourite, Lead, Zinc and Copper.

All three reports are available for free at

About is a leading publisher of financial newsletters and a great place for investors to start their due-diligence on penny stocks and small cap companies. To access free reports on other companies visit Zenect Wealth. For more information about Zenect's marketing, awareness, and media relations services contact our investor relations division at

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND IN THIS REPORT. Neither Zenect LLC nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction. We do not provide, and nothing in this report should be considered, personalized investment advice. We do not have a beneficial interest in the mentioned companies, nor have we received compensation of any kind for the publication of these reports. The information contained in these or any other report is for informational purposes only and is not an offer to buy or sell securities. All information is based on sources believed to be reliable, but no warranty of any kind is made. Please read our full disclosures at

Contact Information